{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T15:48:44Z","timestamp":1780415324773,"version":"3.54.1"},"reference-count":14,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[1997,10,1]],"date-time":"1997-10-01T00:00:00Z","timestamp":875664000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,1,7]],"date-time":"2020-01-07T00:00:00Z","timestamp":1578355200000},"content-version":"vor","delay-in-days":8133,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Annals of Oncology"],"published-print":{"date-parts":[[1997,10]]},"DOI":"10.1023\/a:1008261821434","type":"journal-article","created":{"date-parts":[[2002,12,22]],"date-time":"2002-12-22T13:47:34Z","timestamp":1040564854000},"page":"1049-1051","source":"Crossref","is-referenced-by-count":158,"title":["Severe CPT-11 toxicity in patients with Gilbert's syndrome: Two case reports"],"prefix":"10.1016","volume":"8","author":[{"given":"E.","family":"Wasserman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Myara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Lokiec","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Goldwasser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Trivin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Mahjoubi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.L.","family":"Misset","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Cvitkovic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1023\/A:1008261821434_bb0005","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/1040-8428(96)00211-9","article-title":"The clinical status of irinotecan (CPT-11), a novel water soluble camptothecin analogue: 1996","volume":"24","author":"O'Reilly","year":"1996","journal-title":"Crit Rev Oncol\/Hematol"},{"key":"10.1023\/A:1008261821434_bb0010","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1007\/s002800050595","article-title":"Modulation of glucur-onidation of SN-38, the active metabolite of irinotecan, by valproic acid and phenobarbital","volume":"39","author":"Gupta","year":"1997","journal-title":"Cancer Chemother Pharmacol"},{"key":"10.1023\/A:1008261821434_bb0015","first-page":"3723","article-title":"Metabolic fate of irinotecan in humans: correlation of glucuronidation with diarrhea","volume":"54","author":"Gupta","year":"1994","journal-title":"Cancer Res"},{"key":"10.1023\/A:1008261821434_bb0020","first-page":"707","article-title":"UGT isoform 1.1 (UGT*1.1) glucuronidates SN-38, the active metabolite of irinotecan","volume":"16","author":"Iyer","year":"1997","journal-title":"Proc Am Soc Clin Oncol"},{"key":"10.1023\/A:1008261821434_bb0025","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1056\/NEJM199511023331802","article-title":"The genetic basis of the reduced expression of bilirubin UDP-glucuronosyltransferase 1 in Gilbert's syndrome","volume":"333","author":"Bosma","year":"1995","journal-title":"N Engl J Med"},{"key":"10.1023\/A:1008261821434_bb0030","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1002\/hep.1840100207","article-title":"Enhanced acetaminophen toxicity in rats with bilirubin glucuronyl transferase deficiency","volume":"10","author":"Morais","year":"1989","journal-title":"Hepatology"},{"key":"10.1023\/A:1008261821434_bb0035","first-page":"711","article-title":"Preliminary report on an Oxaliplatin (L-OHP)\/CPT-11 phase I trial in gastrointestinal malignancies: an active combination","volume":"16","author":"Cvitkovic","year":"1997","journal-title":"Proc Am Soc Clin Oncol"},{"key":"10.1023\/A:1008261821434_bb0040","doi-asserted-by":"crossref","first-page":"1767","DOI":"10.1093\/clinchem\/29.10.1767","article-title":"Liquid-chromatographic assay and identification of mono- and diester conjugates of bilirubin in normal serum","volume":"29","author":"Muraca","year":"1983","journal-title":"Clin Chem"},{"key":"10.1023\/A:1008261821434_bb0045","first-page":"113","volume":"2","author":"Feveri","year":"1986","journal-title":"can we learn from analysis of serum bilirubin? J Hepatol"},{"key":"10.1023\/A:1008261821434_bb0050","doi-asserted-by":"crossref","first-page":"2688","DOI":"10.1200\/JCO.1996.14.10.2688","article-title":"Pharmacokinetics and pharmacodynamics of irinotecan during a phase II clinical trial in colorectal cancer","volume":"14","author":"Canal","year":"1996","journal-title":"J Clin Oncol"},{"key":"10.1023\/A:1008261821434_bb0055","first-page":"767","article-title":"Baseline bilirubin and its transient early increase predicts likelihood of severe neutropenia and diarrhea in CPT-II based chemotherapy","volume":"16","author":"Wasserman","year":"1997","journal-title":"Proc Am Soc Clin Oncol"},{"key":"10.1023\/A:1008261821434_bb0060","series-title":"In DeVita VT Jr, Hellman S, Rosenberg SA (eds): Cancer' Principles and Practice of Oncology, Vol 1, 5th ed","first-page":"426","article-title":"Cisplatin and its analogues","author":"O'Dwyer","year":"1997"},{"key":"10.1023\/A:1008261821434_bb0065","series-title":"Proc Am Assoc Cancer Res","first-page":"A513","article-title":"Oxaliplatin (L-OHP): Global safety in 682 patients","author":"Brienza","year":"1994"},{"key":"10.1023\/A:1008261821434_bb0070","series-title":"Proc Am Assoc Cancer Res","first-page":"A1445","article-title":"Oxaliplatin, Transplatin\u00ae (Tp\u00ae ) comparative pharmacokinetics in normal and impaired renal function patients","author":"Massari","year":"1995"}],"container-title":["Annals of Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0923753419639967?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0923753419639967?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/academic.oup.com\/annonc\/article-pdf\/8\/10\/1049\/19480237\/8-10-1049.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,2,21]],"date-time":"2020-02-21T02:12:08Z","timestamp":1582251128000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0923753419639967"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1997,10]]},"references-count":14,"journal-issue":{"issue":"10","published-print":{"date-parts":[[1997,10]]}},"alternative-id":["S0923753419639967"],"URL":"https:\/\/doi.org\/10.1023\/a:1008261821434","relation":{},"ISSN":["0923-7534"],"issn-type":[{"value":"0923-7534","type":"print"}],"subject":[],"published":{"date-parts":[[1997,10]]}}}